Israel
Yemoja Ltd. aims to revolutionize the marine ingredient industry by harnessing the power of microalgae for nutraceuticals, cosmetics, and alternative meat production. Established in 2017 and based in Israel, the company received a significant $9.50M Series A investment from Asor Capital in January 2021.
Yemoja operates cutting-edge photobioreactor-powered systems for cultivating microalgae bio compounds, offering standardized high-value microalgae of any variety at any desired scale. The company's offerings extend to the cosmetic and alternative meat sectors, with the production of external polysaccharide sulphate species for the cosmetic industry and the development of a pioneering microalgae-sourced heme substitute for plant-based burgers that mimics the red juices of real meat, without synthetic additives, aligning with the growing demand for sustainable and clean label alternatives.
Yemoja's dedication to sustainability is evident in its state-of-the-art indoor cultivation facility, which sets a gold standard for climate management and minimal ecological footprint. The company's vision is fueled by a team of marine biology and biotech experts committed to leveraging novel engineering methods to revolutionize the commercial microalgae space.
